Sixty million rural Americans aren’t asking for another strategic framework. They’re asking for care — accessible, affordable, and delivered with dignity. The post Rural America Doesn’t Need Another Framework … It Needs Care by September 2026 appeared first on MedCity News.
It seems like the answer is now ‘yes’. EndPoints reports: Stealth BioTherapeutics said the FDA would not meet its Tuesday deadline for approving or rejecting the company’s drug, elamipretide. It had been seeking regulatory clearance of elamipretide for a rare disease called Barth syndrome, which affects only about 150 people in the US and causes…
Caris Life Sciences applies AI and machine learning to patient samples to detect cancer and as a companion diagnostic guiding the use of targeted cancer therapies. As a commercial-stage company, Caris’s upsized public markets debut is an outlier amid the continuing IPO freeze for clinical-stage biotechs developing new drugs. The post Precision Medicine Firm Caris…
Moving forward, healthcare providers should expect that personalization is a prerequisite for outstanding patient care. Like in other sectors, it will be a critical component that separates market leaders from those left behind. The post How to Scale Patient Empathy in an Overburdened Healthcare System appeared first on MedCity News.
This policy watch reviews recent changes in federal datasets by the Trump administration, including removal of data or variables relating to race or ethnicity or sexual orientation and gender identity.
Cybersecurity experts predict cybersecurity attacks will continue to happen with more sophistication
Collecting patient payments is an ongoing struggle. Bills are confusing, reminders go missed and patients can’t always afford to pay. Rising self-pay costs, new medical debt mitigation regulations, Medicaid changes and staff shortages all put added pressure on billing teams. The result is often poor patient financial experiences, wasted staff time and bad debt. As…
RIVERSIDE, Calif. — California’s gubernatorial election is a year away, and the field of primary candidates is still taking shape. But one persistent issue has already emerged as a leading concern: the cost of health care. At a forum Nov. 7 in the Inland Empire, four Democratic candidates vying to succeed Gov. Gavin Newsom vowed…
Here are some practical strategies to build programs that address these challenges and ultimately achieve real, lasting improvement and patient success. The post Key Components for Intensive Outpatient Program Retention appeared first on MedCity News.
Coultreon Biopharma’s lead drug candidate, acquired from Galapagos, is a small molecule designed to selectively inhibit a novel immunology target called SIK3. The Series A financing will support Phase 2 clinical trials in psoriasis and ulcerative colitis. The post Immunology-Focused Coultreon Adds $125M for Pills That Pack the Punch of Injectable Biologics appeared first on…